India, March 25 -- Shares of Mangoceuticals, Inc. (MGRX) slipped over 25% on Tuesday morning. Earlier, the company announced that it has entered into a Master Distribution Agreement to secure the exclusive licensing and distribution rights for Diabetinol within the United States and Canada.
MGRX is currently trading at $3.5500, down $1.2000 or 25.2632%, on the Nasdaq. The stock opened its trading at $4.7300 after closing Monday at $4.7500. The stock has traded between $2.0700 and $16.8000 in the past 52-week period.
Diabetinol is a plant-based nutraceutical clinically supported and patented extract of citrus peel rich in polymethoxylated flavones (PMFs), including nobiletin and tangeretin. Based on clinical studies performed, these compou...